Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers

Summary

EuRhythDia II is a multicenter, randomized, double-blind controlled study. The rationale of EuRhythdia is to explore the effects of 12 weeks of timed melatonin treatment on circadian rhythm, metabolic control and cardiovascular function in night shift workers. The 12 weeks of intervention will be followed by 12 weeks of washing out.

Timeline

Start

2015-01

Primary completion

2017-03-29

Completion

2017-03-29

Drugs

Indications